Janover Inc Common Stock (JNVR) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 1,002.1%.
| ASSET | % RETURN |
|---|---|
Janover Inc Common Stock (JNVR) | 1,002.12% |
Oncology Institute (TOI) | 981.7% |
X4 Pharmaceuticals (XFOR) | 675.51% |
Regencell Bioscience (RGC) | 471.06% |
Global Interactive Technologies (GITS) | 418.67% |
Dominari (DOMH) | 408.65% |
Abits (ABTS) | 404.7% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 336.77% |
Upexi (UPXI) | 330.83% |
Nutex Health (NUTX) | 285.7% |
CervoMed (CRVO) | 260% |
Oriental Culture Holding (OCG) | 247.06% |
Yoshiharu Global (YOSH) | 233.03% |
Cantor Equity Partners, Inc Class A Ordinary Shares (CEP) | 203.18% |
Junee Limited Ordinary Shares (JUNE) | 197.32% |
ThredUp (TDUP) | 191.67% |
Neuronetics (STIM) | 171.52% |
TMC the metals (TMC) | 167.54% |
DBV Technologies (DBVT) | 159.27% |
Rapid Micro Biosystems (RPID) | 147.25% |
Chimerix (CMRX) | 143.3% |
Vasta Platform (VSTA) | 141% |
908 Devices (MASS) | 140.44% |
Curiositystream (CURI) | 134.44% |
Microbot Medical (MBOT) | 128.95% |
